Obatoclax mesylate (GX15-070) is a small-molecule pan-Bcl-2 family inhibitor that is employed in the treatment of advanced chronic lymphocytic leukaemia [31]. Here, BCL2 is linked to B-cell chronic lymphocytic leukemia.